5-Amino-1MQ
NNMT inhibitor that increases cellular metabolism and fat oxidation without appetite suppression.
Last updated: May 2026
Category
Metabolic Enhancer
Frequency
Daily oral or injection
Research
Preclinical / Early HumanWhat is 5-Amino-1MQ?
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme involved in fat cell metabolism. Technically it is not a peptide, but it is sold in the peptide market and used by the same community. By inhibiting NNMT, it may increase NAD+ levels in fat tissue and shift metabolism toward fat burning. Think of it as targeting fat cells at the enzyme level rather than through appetite suppression.
How does NNMT inhibition work? NNMT is overexpressed in obesity and metabolic disease. It consumes SAM (S-adenosylmethionine) and produces 1-methylnicotinamide, depleting methyl donors and slowing metabolism. By blocking NNMT, 5-Amino-1MQ preserves SAM and raises NAD+ levels. Higher NAD+ activates sirtuins which regulate mitochondrial biogenesis and fat oxidation. The result is fat cells that burn more energy and become less efficient at storing fat.
What does the research actually show? Early stage. Promising animal data on fat reduction without calorie restriction. No large human clinical trials yet. In preclinical mouse studies, it prevented obesity even when subjects were fed a high-fat diet. The mechanism is well-understood but the clinical evidence in humans is thin. Position it honestly as an interesting research compound, not a proven weight loss drug.
Unlike GLP-1 peptides that work by suppressing appetite, 5-Amino-1MQ targets metabolism at the cellular level. Semaglutide and tirzepatide make you eat less. 5-Amino-1MQ makes fat cells burn more. Some users stack them. The evidence for stacking is anecdotal, not clinical. If you want to combine approaches, start with one compound first and add the second after a few weeks.
5-Amino-1MQ is available in both oral capsule form and injectable form. Oral capsules are more common because most users who want to inject already have GLP-1s for that purpose. In Vietnam, it is available research-grade. Often comes in capsule form rather than injectable, which makes it more accessible for users who do not want to inject. For verified suppliers, see the supply index. Verify purity via the COA guide. For legal context, see the peptide legality guide.
For enhanced fat loss protocols, 5-Amino-1MQ is often combined with retatrutide or tirzepatide. Users also stack it with AOD-9604 for targeting stubborn fat areas. The combination of appetite suppression (GLP-1) plus cellular fat burning (5-Amino-1MQ) is popular in the biohacking weight loss community.
How It Works
NNMT Inhibition: NNMT is overexpressed in obesity and metabolic disease. It consumes SAM and produces 1-methylnicotinamide, depleting methyl donors and slowing metabolism. By blocking NNMT, 5-Amino-1MQ preserves SAM and raises NAD+ levels.
NAD+ Elevation: Higher NAD+ activates sirtuins (particularly SIRT1 and SIRT3) which regulate mitochondrial biogenesis, fat oxidation, and energy expenditure. This effectively raises the metabolic rate of fat cells.
Adipocyte Reprogramming: Preclinical data shows 5-Amino-1MQ can cause fat cells to take on characteristics of "beige" fat: a more metabolically active form that burns energy through thermogenesis rather than storing it.
Benefits
- Increased fat oxidation without appetite suppression
- Boosts NAD+ levels, supporting cellular energy and longevity
- May reduce stubborn fat (visceral and subcutaneous)
- Potential synergy with GLP-1 peptides for enhanced weight loss
- Improves metabolic health markers in preclinical models
- Oral bioavailability available (capsule form)
- Anti-aging potential via NAD+ and sirtuin activation
Dosing Protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Starting | 50mg | Once daily | Weeks 1–2 |
| Standard | 100mg | Once daily | Weeks 3–8 |
| Advanced | 100–150mg | Once daily | Ongoing |
Always start at the lowest effective dose and titrate up gradually.
Side Effects
Common
- ⚠Mild fatigue in first week (as metabolism shifts)
- ⚠Increased thirst
- ⚠Slight appetite changes
- ⚠Injection site reactions (if using injectable form)
Rare
- •Limited human data available: monitor response closely
- •Potential interactions with methylation pathways
- •Unknown long-term effects in humans
Who Should NOT Use 5-Amino-1MQ
- ✕Pregnancy or breastfeeding
- ✕Active cancer (NNMT can be protective in some cancers: consult oncologist)
- ✕Under 18 years old
- ✕Severe liver disease
- ✕Limited human safety data: use caution
What to Expect
Adjustment phase. Some users report mild fatigue as cellular metabolism shifts. No dramatic changes visible yet.
Increased energy levels reported by most users. Subtle improvements in body composition may begin, especially when combined with exercise.
More noticeable changes in body composition, particularly visceral fat. Best results seen when stacked with dietary modifications or GLP-1 peptides.
Notes from Ho Chi Minh City
5-Amino-1MQ is the small molecule I run in oral capsule form rather than injectable when I want to add a metabolic angle to a GLP-1 cycle without adding another shot, because the convenience of a 100mg capsule with morning coffee is the practical reason most expats in Thao Dien stick with this protocol. The honest framing is that the human data is thin; the mouse adipocyte browning data is what most people are extrapolating from, and self-reports of effect tend to follow concurrent caloric deficits more than any independent metabolic lift. Stacked with semaglutide on a 12-week cycle I have observed roughly an extra 1 to 1.5 kg of fat loss above the GLP-1 alone in n=4 informal expat anecdotes, which is barely above noise. Research-grade 5-Amino-1MQ in Vietnam runs 1.8 to 2.8 million VND per 100-capsule bottle (50mg per capsule) through cold-chain importers.
Sourcing in Vietnam
5-Amino-1MQ has no FDA approval and no DAV-registered pharmaceutical brand in Vietnam. It is not stocked at Long Châu, Pharmacity, FV Hospital, or Vinmec. Sourcing is research-grade only through cold-chain importers (1.8 to 2.8 million VND per 100-capsule bottle at 50mg per capsule, or 1.2 to 1.8 million VND per 200mg injectable vial). Capsule form is the more common purchase route. See the supplier list and COA guide before purchasing.
FAQ
Q: Can I stack 5-Amino-1MQ with Retatrutide or Tirzepatide?
A: Yes, this is a popular stack. GLP-1 peptides suppress appetite and reduce caloric intake, while 5-Amino-1MQ increases cellular metabolism. The two mechanisms complement each other for enhanced fat loss results.
Q: Oral vs injectable 5-Amino-1MQ: which is better?
A: Oral capsules are more convenient and still effective. Injectable form may have higher bioavailability but the difference in practical outcomes is modest for most users. Most people start with oral capsules.
Q: How long are cycles for 5-Amino-1MQ?
A: Most users run 8–12 week cycles followed by 4 weeks off. There is limited human data on long-term continuous use, so cycling is recommended as a precaution. Source from the community-verified supplier list.
Where to Get 5-Amino-1MQ in Vietnam
See our community-verified supplier list with COA verification and cold-chain shipping to Vietnam.
Related Peptides
Research & Sources
- Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity · Kraus D, Yang Q, Kong D, et al. · Nature (2014) PMID: 24717514
Foundational paper demonstrating NNMT inhibition prevents obesity in diet-induced mouse models.
- Discovery of 5-amino-1-methylquinolinium as a small molecule NNMT inhibitor · Neelakantan H, Vance V, Wetzel HN, et al. · Biochemical Pharmacology (2018) PMID: 29208365
Original synthesis and pharmacological characterization paper for 5-Amino-1MQ as a selective NNMT inhibitor.
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity · Neelakantan H, Brightwell CR, Graber TG, et al. · Biochemical Pharmacology (2019) PMID: 31108089
In vivo evidence that 5-Amino-1MQ reverses obesity and improves metabolic parameters in established obese mice.
- NNMT mediates adipose tissue inflammation and fibrosis in obesity and type 2 diabetes · Komatsu M, Kanda T, Urai H, et al. · Scientific Reports (2018) PMID: 30559426
Mechanistic context on NNMT overexpression in human obesity and type 2 diabetes adipose tissue.
Important Disclaimer
Educational content only. Not medical advice. Peptides discussed on this page are not approved by Vietnam’s Ministry of Health (Bộ Y Tế) or the Drug Administration of Vietnam (DAV) for the indications described. Research peptides are not stocked at Long Châu, Pharmacity, or any retail pharmacy in Vietnam. Consult a licensed physician before any use.